Cancer

INDICATION: Prostate cancer

Cell culture, patient sample and mouse studies suggest inhibiting SMARCA4 could help treat PTEN-deficient prostate cancer. Screening of a CRISPR single-guide RNA

Read the full 240 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE